Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial

BACKGROUND: A single co-administered dose of a triple-drug regimen (ivermectin, diethylcarbamazine, and albendazole) has been shown to be safe and more efficacious for clearing Wuchereria bancrofti microfilariae than the standard two-drug regimen of diethylcarbamazine plus albendazole in clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Laman, Moses, Tavul, Livingstone, Karl, Stephan, Kotty, Bethuel, Kerry, Zebede, Kumai, Stephen, Samuel, Anna, Lorry, Lina, Timinao, Lincoln, Howard, S Cade, Makita, Leo, John, Lucy, Bieb, Sibauk, Wangi, James, Albert, Jeffrey M, Payne, Michael, Weil, Gary J, Tisch, Daniel J, Bjerum, Catherine M, Robinson, Leanne J, King, Christopher L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300473/
https://www.ncbi.nlm.nih.gov/pubmed/35533701
http://dx.doi.org/10.1016/S1473-3099(22)00026-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300473/
https://www.ncbi.nlm.nih.gov/pubmed/35533701
http://dx.doi.org/10.1016/S1473-3099(22)00026-3

Ejemplares similares